Literature DB >> 15928277

Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.

Jayant Dey, Lawrence Blonde, Alan Burshell, Peggy Bolton, Anita Richard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15928277     DOI： 10.1001/jama.293.21.2597-b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Protection of the ischemic myocardium during the reperfusion: between hope and reality.

Authors:  Jean Chrisostome Bopassa
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

2.  High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study.

Authors:  Yanhui Li; Lin Zhang; Lei Zhang; Haiyong Zhang; Nianzhong Zhang; Zhongsu Yang; Mingming Gao; Xinchun Yang; Liang Cui
Journal:  J Cardiovasc Dis Res       Date:  2010-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.